Related Experiment Video
Updated: Sep 16, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
Feasibility of dose accumulation for assessing treatment-related side effects in MR-guided abdominal SABR: A
Rekaya Shabbir1,2, Agnieszka Zakacz1, Ruksana Sivakaran2
1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Oxford Rd, Manchester, M13 9PL, UK.
Background:
Daily adaptive magnetic resonance (MR)-guided treatment changes delivered dose distributions, making cumulative dose uncertain. This work assessed the feasibility of exploring potential relationships between side effects and accumulated dose (AD) in MR-guided stereotactic ablative radiotherapy (SABR) for liver and pancreatic cancers. Using deformable image registration (DIR), AD to abdominal organs at risk (OARs) were estimated and potential relationships with observed side effects explored.
Methods:
Forty-one patients treated with 5-fraction MR-guided SABR to primary or metastatic pancreatic and liver tumours were retrospectively included. Daily adapted plans were deformably mapped and summed to estimate AD. Differences between accumulated and planned dose were assessed. Changes in clinician-reported symptoms collected at baseline, 3, and 6 months were analysed. Associations between AD and symptoms were assessed using Spearman's rank test.
Results:
Most AD metrics were lower than planned for gastrointestinal OARs, reflecting potential differences from delivered ATS plans, with significant reductions in duodenum and large bowel D0.5cc and D10cc (p < 0.001). Weak associations between small bowel dose metrics and acute and subacute diarrhoea were found (rs 0.4-0.5, p < 0.040). All side effects were ≤ grade (G) 2. Median overall survival for locally advanced pancreatic cancer (LAPC) patients was 16.0 months post-SABR and was not reached for other subgroups.
Conclusion:
Exploring potential relationships between DIR-based accumulated OAR dose and side effects was feasible. Preliminary relationships between accumulated OAR dose and side effects were observed; however, further work in larger studies is warranted before these findings can be used to personalise treatment in the future.
Related Concept Videos
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Modified-Release Drug Delivery Systems: Bioavailability
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...